Researchers say they are getting close to developing medicine totreat the dreaded norovirus, or what is commonly referred to as the stomach bug.
Currently, there is no vaccine or antiviral drug to treat thevirus, which has symptoms that include vomiting, diarrhea, stomach pain and nausea.
Infections are usually foodborne and are commonly contracted in public places like hospitals, schools andcruise ships.
"We are dealing with an existing problem so that's why wethink this is very, very important to do, finding those antivirals against thisnorovirus," said Dr. Kyeong-Ok Chang, a pathobiologist at Kansas State University.
The university is partnering with researchers from Wichita State University, Ohio State University and the pharmaceutical company Macrobiotics indeveloping the antiviral drug.
The team has tested more than a thousand compounds toidentify one that can treat norovirus. The researchers have found several with the best potentialfor further drug development.